Johnson & Johnson (JNJ) Shares Dip After Revenue Miss, Suspended COVID Vaccine Sales Guidance; Results Seen as 'Mixed'
Go back to Johnson & Johnson (JNJ) Shares Dip After Revenue Miss, Suspended COVID Vaccine Sales Guidance; Results Seen as 'Mixed'| Johnson & Johnson (NYSE: JNJ) | Delayed: 275.23 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $275.23 | 52 Week High | $126.07 | |||
| Open | $275.23 | 52 Week Low | $94.28 | |||
| Day High | $275.23 | P/E | 57.22 | |||
| Day Low | $275.23 | EPS | $4.81 | |||
| Volume | 27,641 | |||||

